Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Videos
09/12/2019
Cathy Eng, MD, FACP, FASCO, discusses the latest developments in anal cancer over the past 12 months.
Cathy Eng, MD, FACP, FASCO, discusses the latest developments in anal cancer over the past 12 months.
Cathy Eng, MD, FACP, FASCO,...
09/12/2019
Oncology
Test Your Knowledge
08/27/2019
Durvalumab therapy plus _______ was well-tolerated but demonstrated poor activity in a study of patients with metastatic pancreatic ductal adenocarcinoma.
Durvalumab therapy plus _______ was well-tolerated but demonstrated poor activity in a study of patients with metastatic pancreatic ductal adenocarcinoma.
Durvalumab therapy plus _______...
08/27/2019
Oncology
Interview
08/27/2019
Tomoki Makino, MD, PhD, discusses how lymph node response more accurately predicts survival in esophageal cancer than primary tumor response.
Tomoki Makino, MD, PhD, discusses how lymph node response more accurately predicts survival in esophageal cancer than primary tumor response.
Tomoki Makino, MD, PhD,...
08/27/2019
Oncology
Debates and Roundtables
08/13/2019
Axel Grothey, MD; Josep Tabernero, MD, PhD; and Scott Kopetz, MD, PhD, FACP, discuss the findings and clinical significance of the BEACON CRC trial.
Axel Grothey, MD; Josep Tabernero, MD, PhD; and Scott Kopetz, MD, PhD, FACP, discuss the findings and clinical significance of the BEACON CRC trial.
Axel Grothey, MD; Josep...
08/13/2019
Oncology
Videos
07/25/2019
Andrea Sartore Bianchi, MD, discusses the HER2 Pathway in gastrointestinal cancer at the 2019 ESMO World Congress on Gastrointestinal Cancer.
Andrea Sartore Bianchi, MD, discusses the HER2 Pathway in gastrointestinal cancer at the 2019 ESMO World Congress on Gastrointestinal Cancer.
Andrea Sartore Bianchi, MD,...
07/25/2019
Oncology
Interview
07/24/2019
Ramesh A. Shivdasani, MD, PhD, discusses a study that unveiled molecular information predicting the risk for recurrence of non-functional pNETs.
Ramesh A. Shivdasani, MD, PhD, discusses a study that unveiled molecular information predicting the risk for recurrence of non-functional pNETs.
Ramesh A. Shivdasani, MD, PhD,...
07/24/2019
Oncology
Videos
07/06/2019
Rachel Riechelmann, MD, PhD, gives an update on what's new in gastrointestinal and pancreatic NETs in the past year.
Rachel Riechelmann, MD, PhD, gives an update on what's new in gastrointestinal and pancreatic NETs in the past year.
Rachel Riechelmann, MD, PhD,...
07/06/2019
Oncology
Videos
07/06/2019
David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
David H. Ilson, MD, PhD, explains why radiotherapy should be included as part of adjuvant therapy for gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
David H. Ilson, MD, PhD,...
07/06/2019
Oncology
Videos
07/06/2019
Andrés Cervantes, MD, PhD, discusses new therapeutic agents for advanced gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
Andrés Cervantes, MD, PhD, discusses new therapeutic agents for advanced gastric cancer at the ESMO 21st World Congress on Gastrointestinal Cancer.
Andrés Cervantes, MD, PhD,...
07/06/2019
Oncology
Videos
05/07/2019
In this 3-part video series, Dr Ilson discusses the current adjuvant treatment landscape for patients with gastric cancer.
In this 3-part video series, Dr Ilson discusses the current adjuvant treatment landscape for patients with gastric cancer.
In this 3-part video series, Dr...
05/07/2019
Oncology

Advertisement

Advertisement

Advertisement

Advertisement